Advanced glycation endproducts and their pathogenic roles in neurological disorders (Q37800424)

23 August 2017

title

Advanced glycation endproducts and their pathogenic roles in neurological disorders (English)

1 reference

23 August 2017

Gerald Münch

1

1 reference

23 August 2017

Bernadette Westcott

series ordinal

2

1 reference

23 August 2017

Teresita Menini

series ordinal

3

1 reference

23 August 2017

Alejandro Gugliucci

series ordinal

4

1 reference

23 August 2017

publication date

14 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

42

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

1221-1236

1 reference

https://scigraph.springernature.com/pub.10.1007/s00726-010-0777-y

23 August 2017

exact match

0 references

cites work

Advanced glycation endproducts--role in pathology of diabetic complications

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Protracted juvenile neuronal ceroid lipofuscinosis--an autopsy report and immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Neuropil threads occur in dendrites of tangle-bearing nerve cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Acrolein‐sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

The role of bound lipid and transition metal in the formation of fluorescent advanced glycation endproducts by human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Diabetes preceding Parkinson's disease onset. A case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Evidence of oxidative stress in the neocortex in incidental Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycation endproducts change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Protein "AGEing"--cytotoxicity of a glycated protein increases with its degree of AGE-modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and 'advanced glycation endproducts' in a murine microglia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycation: implications in tissue damage and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Genetics of familial and sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Crystal structure of the protein histidine phosphatase SixA in the multistep His-Asp phosphorelay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Effect of carbonyl compounds on red blood cells deformability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

An immunochemical study on tau glycation in paired helical filaments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Cognitive dysfunction and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Differential effects of "Advanced glycation endproducts" and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Nonenzymatic browning in vivo: possible process for aging of long-lived proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Coffee and Maillard products activate NF-kappaB in macrophages via H2O2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

How does glucose generate oxidative stress in peripheral nerve?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Update on the pathogenesis of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Diabetes and the peripheral nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Triosephosphate isomerase deficiency: a neurodegenerative misfolding disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycoxidation products and impaired diabetic wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Diabetic neuropathy--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Triosephosphate isomerase deficiency: historical perspectives and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Molecular biological approaches to neurological disorders including knockout and transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Alzheimer disease: an imbalance of proteolytic regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Amyloidosis, advanced glycation end products and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Degradation of glycated bovine serum albumin in microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Role of advanced glycation end products in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

[New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs)].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Modification of the glyoxalase system in human red blood cells by glucose in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

The potential role of thiamine (vitamin B1) in diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Role of the Maillard reaction in diabetes mellitus and diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

RAGE, diabetes, and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Alpha-lipoic Acid and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

The sour side of neurodegenerative disorders: the effects of protein glycation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Diabetic neuropathies: clinical manifestations and current treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

Tau and transgenic animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-010-0777-Y

10.1007/S00726-010-0777-Y

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference